Effect of dual lipid-lowering therapy on coronary plaques in patients with coronary artery disease: systematic review and meta-analysis

Eur J Prev Cardiol. 2023 Nov 30;30(17):e84-e86. doi: 10.1093/eurjpc/zwad248.

Authors

Mohil Garg¹, Jose Antonio Sorolla Romero², Umer A Esbhani¹, Jorge Sanz Sánchez^{3

4}, Hector M Garcia-Garcia⁵

Affiliations

¹ Department of Internal Medicine, MedStar Washington Hospital Center, Washington, DC, USA.
² Universitario y Politécnico La Fe, Valencia, Spain.
³ Hospital Universitari i Politecnic La Fe, Valencia, Spain.
⁴ Centro de Investigación Biomedica en Red (CIBERCV), Madrid, Spain.
⁵ Department of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA.

PMID: 37490772
DOI: 10.1093/eurjpc/zwad248

No abstract available

Publication types

Meta-Analysis
Systematic Review
Letter
Comment

MeSH terms

Coronary Angiography
Coronary Artery Disease* / complications
Coronary Artery Disease* / drug therapy
Coronary Vessels / diagnostic imaging
Heart
Humans
Lipids
Plaque, Atherosclerotic*

Substances

Lipids